| Primary |
| Drug Use For Unknown Indication |
39.5% |
| Hypertension |
21.8% |
| Cardiac Failure |
9.1% |
| Atrial Fibrillation |
4.6% |
| Tuberculosis |
4.2% |
| Self Mutilation |
3.5% |
| Thrombosis Prophylaxis |
2.1% |
| Diabetes Mellitus |
1.8% |
| Product Used For Unknown Indication |
1.6% |
| Angina Pectoris |
1.4% |
| Cardiac Failure Chronic |
1.4% |
| Bronchitis |
1.1% |
| Hyperthyroidism |
1.1% |
| Hyperuricaemia |
1.1% |
| Infection |
1.1% |
| Oedema |
1.1% |
| Periarthritis |
1.1% |
| Ventricular Extrasystoles |
1.1% |
| Cardiomyopathy |
0.9% |
| Gastritis |
0.9% |
|
| White Blood Cell Count Increased |
10.9% |
| Liver Disorder |
9.8% |
| Shock |
8.7% |
| Pyrexia |
7.6% |
| Ventricular Tachycardia |
7.6% |
| Overdose |
5.4% |
| Sinus Arrest |
5.4% |
| Red Blood Cell Count Decreased |
4.3% |
| Renal Failure |
4.3% |
| Renal Impairment |
4.3% |
| Blood Creatine Phosphokinase Increased |
3.3% |
| Hepatic Function Abnormal |
3.3% |
| Hypertensive Encephalopathy |
3.3% |
| Pulse Absent |
3.3% |
| Renal Failure Acute |
3.3% |
| Somnolence |
3.3% |
| Stevens-johnson Syndrome |
3.3% |
| Torsade De Pointes |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Agranulocytosis |
2.2% |
|
| Secondary |
| Hypertension |
30.9% |
| Drug Use For Unknown Indication |
10.7% |
| Cardiac Failure |
8.5% |
| Myocardial Infarction |
7.8% |
| Angina Pectoris |
6.4% |
| Diabetes Mellitus |
4.8% |
| Thrombosis Prophylaxis |
3.8% |
| Atrial Fibrillation |
3.1% |
| Cardiac Failure Chronic |
3.1% |
| Gastritis Prophylaxis |
2.6% |
| Percutaneous Coronary Intervention |
2.3% |
| Hyperlipidaemia |
2.3% |
| Hypercholesterolaemia |
2.2% |
| Depression |
1.9% |
| Emphysema |
1.9% |
| Hyperuricaemia |
1.6% |
| Infection |
1.6% |
| Constipation |
1.4% |
| Gastric Ulcer Haemorrhage |
1.4% |
| Arrhythmia |
1.4% |
|
| Liver Disorder |
13.1% |
| Liver Function Test Abnormal |
12.5% |
| Angina Pectoris |
6.9% |
| Thrombocytopenia |
5.6% |
| Cardiac Failure |
5.0% |
| Renal Failure Acute |
5.0% |
| Rhabdomyolysis |
5.0% |
| Pyrexia |
4.4% |
| Renal Impairment |
4.4% |
| Shock |
4.4% |
| Acute Generalised Exanthematous Pustulosis |
3.8% |
| Hepatic Function Abnormal |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Tonic Convulsion |
3.8% |
| Cerebral Infarction |
3.1% |
| Hyperkalaemia |
3.1% |
| Platelet Count Decreased |
3.1% |
| Pneumonia |
3.1% |
| Suicide Attempt |
3.1% |
| Toxic Skin Eruption |
3.1% |
|
| Concomitant |
| Hypertension |
23.8% |
| Cardiac Failure |
11.7% |
| Product Used For Unknown Indication |
7.9% |
| Drug Use For Unknown Indication |
6.3% |
| Prophylaxis |
6.0% |
| Diabetes Mellitus |
4.6% |
| Cardiac Failure Chronic |
4.6% |
| Angina Pectoris |
4.5% |
| Atrial Fibrillation |
3.9% |
| Hyperlipidaemia |
3.3% |
| Constipation |
3.1% |
| Myocardial Infarction |
3.0% |
| Rheumatoid Arthritis |
2.8% |
| Insomnia |
2.7% |
| Acute Myocardial Infarction |
2.6% |
| Type 2 Diabetes Mellitus |
2.4% |
| Hyperuricaemia |
2.1% |
| Gastritis |
2.1% |
| Gastric Ulcer |
1.3% |
| Herpes Zoster |
1.3% |
|
| Interstitial Lung Disease |
10.3% |
| Renal Impairment |
9.4% |
| White Blood Cell Count Decreased |
6.7% |
| Vomiting |
6.6% |
| Pneumonia |
6.3% |
| Hepatic Function Abnormal |
6.1% |
| Thrombocytopenia |
5.0% |
| White Blood Cell Count Increased |
4.9% |
| Death |
4.7% |
| Renal Failure Acute |
4.7% |
| Pyrexia |
4.6% |
| Rhabdomyolysis |
4.4% |
| Renal Failure |
4.1% |
| Hypoglycaemia |
3.7% |
| Platelet Count Decreased |
3.7% |
| Cardiac Failure |
3.4% |
| Urinary Tract Infection |
3.0% |
| Myocardial Infarction |
2.9% |
| Hyponatraemia |
2.7% |
| Rash |
2.7% |
|
| Interacting |
| Disseminated Tuberculosis |
38.3% |
| Hypertension |
25.2% |
| Diabetes Mellitus |
10.4% |
| Cardiac Failure Chronic |
5.2% |
| Cerebral Infarction |
5.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.2% |
| General Anaesthesia |
2.6% |
| Ischaemic Cardiomyopathy |
2.6% |
| Cardiac Failure |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Aortic Valve Replacement |
0.9% |
| Nail Tinea |
0.9% |
|
| Hypertensive Encephalopathy |
38.9% |
| Surgery |
33.3% |
| Hepatic Failure |
11.1% |
| Renal Failure Acute |
5.6% |
| Salivary Gland Neoplasm |
5.6% |
| Vomiting |
5.6% |
|
